Celbrea®
Early detection of breast disease (adjunctive tool)
CommercialActive
Key Facts
Indication
Early detection of breast disease (adjunctive tool)
Phase
Commercial
Status
Active
Company
About Welwaze Medical
Welwaze Medical is a private, commercial-stage digital health company focused on breast cancer detection through its flagship product, Celbrea®, a thermal biomarker device. The company integrates a medical device, a mobile application, and AI on a blockchain-powered platform to provide adjunctive tools for physicians and patients. Led by founder and CEO Alex J. Ness, Welwaze has garnered several innovation awards and is positioned to disrupt the breast cancer diagnostics market with its human-first, technology-driven approach.
View full company profile